Adaptive Biotechnologies Corporation
ADPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $9,546 | -$25,593 | -$29,852 | -$33,717 |
| Dep. & Amort. | $4,405 | $4,502 | $4,731 | $4,448 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $13,359 | $0 | $12,832 |
| Change in WC | -$33,868 | -$5,305 | -$16,143 | $3,053 |
| Other Non-Cash | $12,790 | $607 | $12,780 | $893 |
| Operating Cash Flow | -$7,127 | -$12,430 | -$28,484 | -$12,491 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$409 | -$655 | -$1,259 | -$80 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$33,191 | -$51,138 | -$50,654 | -$44,799 |
| Inv. Sales/Matur. | $50,883 | $55,139 | $77,486 | $66,998 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17,283 | $3,346 | $25,573 | $22,119 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,684 | $1,610 | $5,451 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $127 |
| Financing Cash Flow | $1,684 | $1,610 | $5,451 | $127 |
| Forex Effect | $31 | $0 | $186 | $0 |
| Net Chg. in Cash | $11,871 | -$7,474 | $2,726 | $9,755 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43,163 | $53,357 | $47,920 | $41,062 |
| End Cash | $55,034 | $45,883 | $50,646 | $50,817 |
| Free Cash Flow | -$7,536 | -$13,085 | -$29,743 | -$12,571 |